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Background: In light of declining autopsy rates around the world, post-mortem MR imaging is a promising
alternative to conventional autopsy in the investigation of infant death. A major drawback of this non-invasive
autopsy approach is the fact that histopathological and microbiological examination of the tissue is not possible.
The objective of this prospective study is to compare the performance of minimally invasive, virtual autopsy,
including CT-guided biopsy, with conventional autopsy procedures in a paediatric population.
Methods/Design: Foetuses, newborns and infants that are referred for autopsy at three different institutions
associated with the University of Zurich will be eligible for recruitment. All bodies will be examined with a
commercial CT and a 3 Tesla MRI scanner, masked to the results of conventional autopsy. After cross-sectional
imaging, CT-guided tissue sampling will be performed by a multifunctional robotic system (Virtobot) allowing for
automated post-mortem biopsies. Virtual autopsy results will be classified with regards to the likely final diagnosis
and major pathological findings and compared to the results of conventional autopsy, which remains the diagnostic
gold standard.
Discussion: There is an urgent need for the development of alternative post-mortem examination methods, not only
as a counselling tool for families and as a quality control measure for clinical diagnosis and treatment but also as an
instrument to advance medical knowledge and clinical practice. This interdisciplinary study will determine whether
virtual autopsy will narrow the gap in information between non-invasive and traditional autopsy procedures.
Trial Registration: ClinicalTrials.gov: NCT01888380
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Despite the long-standing clinical success of post-
mortem examinations [1], there has been a sustained
decline in autopsy rates around the world [2]. This devel-
opment has been observed not only in adults, but even
more frequently in neonates, infants and children [3-5].
This is in spite of the fact that perinatal and paediatric
autopsies present particular value in several regards.
First, perinatal post-mortem examinations allow for
the identification of genetic and obstetric factors that are
of relevance to the management of future pregnancies,
allowing for appropriate counselling of families. In ap-
proximately 30% of cases following termination of preg-
nancies, foetal autopsy changed the recurrence risk
associated with those parents [6,7]. Second, foetal and
paediatric autopsies are important in confirming or re-
futing pre-morbid diagnoses, and present information
pertinent to further specific diagnoses. Stambouly et al.
demonstrated that paediatric autopsies reveal additional
findings in up to 50% of cases, approximately 10% of
which identified diagnoses that may have prevented
death had they been known [8]. Finally, in addition to
the benefits to individuals and families, autopsy has the
potential to advance medical knowledge and improve
clinical practice [9].
The reasons for the decrease in autopsy rates are
multifactorial and complex. Importantly, a large major-
ity of parents deny consent to autopsy because of con-
cerns about disfigurement of their deceased child
during the procedure. The desire for their infant to
“be left in peace” and scepticism concerning other po-
tential benefits or detriments are additional causes for
this denial [10,11]. Additionally, the controversial per-
ception that improved technology renders the autopsy
redundant may have altered the interest and attitude
of the public and clinicians towards traditional post-
mortem examinations.
Questions have therefore arisen regarding the merit of
traditional autopsy as a means of quality control for clin-
ical diagnosis and treatment. For this reason, many clini-
cians have called for a minimally invasive autopsy
technique that may be better accepted by parents and
healthcare professionals and could therefore provide an
alternative for those parents for whom traditional aut-
opsy is not an option. Previous studies have indicated a
better acceptance of such an autopsy approach among
both healthcare professionals [12] and parents [13].
Less invasive methods, such as post-mortem ultrasound-
and laparoscopic examinations [14], have been reported
in the last two decades. However, these methods did not
gain widespread acceptance due to a lack of evidence
from studies comparing such an approach with conven-
tional autopsy in a rigorous and blinded manner. Post-
mortem magnetic resonance imaging (post-mortem MRI)and computed tomography (CT), which are generically
referred to as post-mortem cross-sectional imaging [15],
are other non-invasive autopsy techniques first reported
in 1996 [16]. The procedures have the advantage of deter-
mining the position of the different organs in situ while
maintaining the integrity of the human body. Numerous
studies have now investigated the diagnostic accuracy of
post-mortem MRI compared to conventional autopsy.
Most of them showed good results in the detection of
central nervous system abnormalities, but relatively
poor results for the detection of cardiac anomalies
[17-21]. The most recent and so far the largest, pro-
spective validation study in foetuses and children dem-
onstrated an overall concordance of 89.3% regarding
the cause of death or major pathological lesions de-
tected by minimally invasive autopsy (post-mortem
MRI and blood sampling) compared with conventional
autopsy [22]. In children and adolescents, the concord-
ance was generally lower than in foetuses (53.6% vs.
94.6%), mainly because of undetected sepsis affecting
the lungs, the heart, and the intestine, or because of
disseminated sepsis.
In such scenarios, analysis of microstructure at the
electron microscopic level as well as specific staining,
would be informative [23]. However, this is not possible
with an imaging-based, non-invasive autopsy approach.
To overcome this shortcoming, percutaneous organ bi-
opsies with or without image guidance have been pro-
posed [24,25]. Biopsies leave only minor lesions and
enable processing of specimens in a similar manner as
those obtained by conventional autopsy. Major limita-
tions include the relatively small amount of tissue that
can be collected and the risk that the best representative
parts are missed. Breeze et al. investigated the feasibility
of percutaneous foetal organ biopsies using ultrasound
guidance ± surface landmarks in the context of a minim-
ally invasive autopsy. They reported that this technique
cannot yet be considered to provide useful clinical infor-
mation, because less than 50% of all biopsies were ad-
equate for histological examination [26]. Percutaneous
needle biopsies under CT guidance are therefore sug-
gested to be a more reliable method for targeted sam-
pling of tissue probes, narrowing the information gap
between non-invasive and traditional autopsy [27]. How-
ever, a large prospective study of such a minimally inva-
sive autopsy approach by post-mortem cross-sectional
imaging and CT-guided biopsies in foetuses, newborns
and infants has not been conducted. With the proposed
interdisciplinary study, we aim to compare the perform-
ance of combined cross-sectional imaging and CT-guided
biopsy with conventional autopsy. For this project, an
approach that combines post-mortem imaging and im-
aging guided biopsies is defined as minimally invasive or
virtual autopsy.




TR (ms) TI (ms) TE (ms) IR delay
(ms)
Body Imaging
T2 coronal 2 2969 100
T2 SPIR coronal 2 3155 100
T1 IR coronal 2 7000 600 15 600
T2 axial 2 4000 80
T2 SPIR axial 2 3341 60
T1 IR axial 2 7000 600 15 600
T2 sagittal 2 2969 100
Brain Imaging
T2 axial 2 5531 50
FLAIR axial 2 12000 2850 140 2850
T1 IR axial 2 7000 600 15 600
TR, relaxation time, TI, inversion time, TE, echo time, IR, inversion recovery,
mm, millimetre, ms, millisecond, SPIR, spectral presaturation with inversion
recovery, FLAIR, fluid attenuated inversion recovery.
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Trial design
This is a prospective, comparative, interdisciplinary, clin-
ical trial with three study sites: the Department of
Neonatology of the University Hospital Zurich, the Chil-
dren’s University Hospital Zurich and the Institute of
Forensic Medicine. All three study sites are associated
with a single academic institution – the University of
Zurich, Switzerland. Consecutive foetuses, newborns and
infants that are referred for autopsy at these three insti-
tutions will be eligible for recruitment into the study. All
recruited cases will undergo post-mortem imaging (MRI
and CT) with CT-guided biopsies in addition to conven-
tional autopsy.
The study protocol was submitted Ethical Committee
of the Canton Zurich and received a waiver from ethics
approval. Clinical trial registration was made at clinical-
trials.gov under the number NCT01888380. The study
will be conducted in accordance with principles enunci-
ated in the current version of the Declaration of
Helsinki, the guidelines of Good Clinical Practice issued
by the International Conference on Harmonization, and
the requirements of the Swiss regulatory authority. With
the exception of forensic cases, parental consent will be
required for each subject.
Inclusion and exclusion criteria
Inclusion criteria for participation in the paediatric vir-
tual autopsy trial comprise still- and live-born infants
from 16 weeks of gestational age up to 12 months post-
natal age regardless of the manner of death (trauma,
homicide, or intoxication). Deceased infants who are
organ donors will be excluded from the study.
Objectives
Our primary objective is to compare the accuracy of
post-mortem imaging combined with guided biopsy for
the detection of the cause of death and/or major patho-
logical lesions to that of conventional autopsy in foe-
tuses, newborns and infants. Secondary objectives
primarily aim to evaluate which clinical indications are
best suited to each of the two approaches. Second, we
aim to optimise a protocol for MRI examinations in de-
ceased neonates, infants and children. Third, this study
aims to report the number of cases in which there is a
change in the ante-mortem diagnosis following post-
mortem cross-sectional imaging using CT-guided biopsy.
Recruitment
As routinely practiced, post-mortem examinations will
be offered for all foetuses, newborns and infants up to
12 months of age regardless of whether the death was
due to a natural or non-natural cause. In non-medical
legal cases, parents will be approached by appropriatelytrained staff (a consultant or an experienced midwife)
and asked if they consent to an autopsy for their child. If
parents agree, a precedent cross sectional imaging with
CT-guided biopsy will be proposed. They will receive an
information leaflet and at least one parent must give
written consent.
Post-mortem imaging
All bodies will be examined with a commercial dual-
source CT (Somatom Definition; Siemens Medical Solu-
tions, Forchheim, Germany) and a 3 Tesla MRI scanner
(Philips Achieva; Philips Medical Systems, Best, The
Netherlands) at the Institute of Forensic Medicine, Uni-
versity of Zurich. MR images will be acquired as given in
Table 1 and will include the complete foetal or infant
body from the calvarium through the lower extremities.
The first 30 subjects will be used to improve the imaging
sequences and to optimise the robotic system allowing
for CT-guided tissue sampling. These subjects will not
be included in the main study. Initially, a specialised fo-
rensic radiologist (S.R.) with 6 years of experience in
post-mortem radiology will report the results of MR and
CT imaging in a large internet-based secure database
(SecuTrial®). All diagnoses will be specified according to
the international classification of diseases (ICD-10).
CT-guided tissue sampling
After cross-sectional imaging, CT-guided tissue sam-
pling will be performed by a multifunctional robotic sys-
tem at the Institute of Forensic Medicine, University of
Zurich. This “Virtobot System” allows for automated
post-mortem biopsies and is composed of a six-axis in-
dustrial robotic arm (Stäubli TX90L; Stäubli, Freienbach,
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aligned with the CT table [28]. For performing biopsies,
the Virtobot has been combined with a surgical naviga-
tion system. Under close monitoring by a forensic path-
ologist specialising in paediatric forensic medicine, the
same predefined organs (surface of the brain including
the meninges, upper and lower lobes of the lung, right
and left lobe of the thymus, right and left heart ventricle,
right and left lobe of the liver, both kidneys, adrenal
glands, pancreas, and spleen) will be biopsied in each
case. Additional samples will be taken if, based on im-
aging, a focal abnormality is suspected. Specimens will
be fixated in formalin and examined by an independent
pathologist, who is blinded to the results of post-
mortem imaging and conventional autopsy results. An-
cillary tests include the minimally invasive examination
of the placenta and umbilical cord and CT-guided ex-
traction of blood, urine, and cerebrospinal fluid for
microbiological diagnostics (cultures).
Virtual autopsy – final classification
Based on cross-sectional imaging, histology and ancillary
test results, the findings will be reclassified with regard
to the likely final diagnosis and major pathological find-
ings. An interdisciplinary team (forensic radiologist,
forensic pathologist and pathologist) blinded to the find-
ings of the conventional autopsy will decide whether one
or several pathological findings are present for each
organ system. This final classification based on virtual
autopsy will be reported in the same database and speci-
fied according to the ICD-10.
Conventional autopsy
All conventional autopsies, the gold standard against
which the virtual autopsy is assessed, will be performed
by experienced perinatal, paediatric and forensic pathol-
ogists according to the guidelines of the Swiss Society of
Pathology [29]. A database with independent access
portals will be used to maintain blinding from virtual
autopsy results. For each organ system, the same cat-
egorisation (likely final diagnosis and major pathological
findings) will be used and specified according to the
ICD-10.
Sample size calculation and statistical analysis
A sample size of 100 cases allows for the computation of
a 95% confidence interval of width +/− 8% for the pri-
mary outcome if the true percentage of cases for which
virtual autopsy correctly identifies the diagnostic cat-
egory is 80%. The width of the confidence interval will
decrease to +/− 6% if the true percentage is 90%, and
further decrease to +/− 4% if the true percentage is 95%.
This precision is considered as sufficient to determine
the quality of virtual autopsy.The diagnoses established by the two methods and by
the two independent teams will be compared, with the
autopsy results considered the gold standard. The pri-
mary outcome will be the percentage of cases for which
virtual autopsy correctly identifies the diagnostic cat-
egory, which will be given together with a 95% confi-
dence interval. Sensitivity, specificity and predictive
values will be calculated for each diagnostic category, as
referenced to the gold standard, again with a 95% confi-
dence interval. Because of the small sample sizes, the
confidence interval by Wilson will be used throughout,
as recommended in Altman et al. in Chapters 6 and 10
[30]. Finally, the results of the virtual autopsy will be
assessed with regard to the accuracy of associated le-
sions, the clinical utility of the information and the de-
termination of the cause of death.
Discussion
Based on previous research, post-mortem MRI appears
to be a promising alternative to conventional autopsy in
foetuses, newborns and infants. The only disadvantage
of the imaging based autopsy is the fact that tissue for
histopathological and microbiological examination can-
not be collected, resulting in a poor accuracy of MRI
due to the fact that infection is a primary cause of death
in older infants and children.
This study protocol describes the design of a new
paediatric virtual autopsy trial, which employs a minim-
ally invasive autopsy procedure that includes tissue sam-
pling with the aid of a robotic system. To the best of our
knowledge, this is the first prospective study to evaluate
the accuracy of such a virtual autopsy approach com-
pared to conventional autopsy procedures in a paediatric
population.
Abbreviations
CT: Computed tomography; ICD: International classification of diseases;
MRI: Magnetic resonance imaging.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
CR is responsible for the conception, design and conduct of the study. CR
developed a data collection system and drafted the study protocol. CB will
be responsible for the minimally invasive virtual autopsy. SR will interpret the
cross-sectional imaging data and report together with CB, RM, and SAB the
final classification based on virtual autopsy. BK will give administrative
support. LH will be responsible for the statistical analyses. EB will process the
tissue derived from virtual autopsies and will report the results of the
histological examination. PKB and RC will perform conventional autopsies. BF
and LS provided input into the clinical aspects of the study and will be
responsible for the recruitment of the cases. HUB has overall responsibility
for the study and advised on the conception, design and conduct of the
study. He critically revised the article. All authors read and approved the final
manuscript.
Funding
C.R. was supported by a Swiss National Science Foundation (SNSF) Career
Award for Medical Scientists (33CM30_140334).
Rüegger et al. BMC Pediatrics 2014, 14:15 Page 5 of 5
http://www.biomedcentral.com/1471-2431/14/15Author details
1Department of Neonatology, University Hospital Zurich, Zurich, Switzerland.
2University Children’s Hospital, Zurich, Switzerland. 3Institute of Forensic
Medicine, University of Zurich, Zurich, Switzerland. 4Division of Biostatistics,
University of Zurich, Zurich, Switzerland. 5Institute for Pathology, University
Hospital Basel, Basel, Switzerland. 6Department of Pathology, University
Hospital Zurich, Zurich, Switzerland. 7Division of Obstetrics, University
Hospital Zurich, Zurich, Switzerland.
Received: 2 August 2013 Accepted: 17 January 2014
Published: 20 January 2014
References
1. Dorsey DB: A perspective on the autopsy. Am J Clin Pathol 1978, 69:217–219.
2. Shojania KG, Burton EC: The vanishing nonforensic autopsy. N Engl J Med
2008, 358:873–875.
3. Brodlie M, Laing IA, Keeling JW, McKenzie KJ: Ten years of neonatal autopsies
in tertiary referral centre: retrospective study. BMJ 2002, 324:761–763.
4. Swinton CH, Weiner J, Okah FA: The neonatal autopsy: can it be revived?
Am J Perinatol 2013, 30:739–744.
5. Adappa R, Paranjothy S, Roberts Z, Cartlidge PHT: Perinatal and infant
autopsy. Arch Dis Child Fetal Neonatal Ed 2007, 92:F49–F50.
6. Akgun H, Basbug M, Ozgun MT, Canoz O, Tokat F, Murat N, Ozturk F:
Correlation between prenatal ultrasound and fetal autopsy findings in
fetal anomalies terminated in the second trimester. Prenat Diagn 2007,
27:457–462.
7. Picone O, Levaillant J-M, Hirt R, Frydman R, Boulvain M, Senat M-V:
Correlation between referral ultrasound with suspected foetal anomalies
and autopsy examination in two prenatal diagnosis centres. Impact of
the routine use of 3D/4D scan. Prenat Diagn 2008, 28:191–196.
8. Stambouly JJ, Kahn E, Boxer RA: Correlation between clinical diagnoses
and autopsy findings in critically ill children. Pediatrics 1993, 92:248–251.
9. Burton JL, Underwood J: Clinical, educational, and epidemiological value
of autopsy. The Lancet 2007, 369:1471–1480.
10. McHaffie HE, Fowlie PW, Hume R, Laing IA, Lloyd DJ, Lyon AJ: Consent to
autopsy for neonates. Arch Dis Child Fetal Neonatal Ed 2001, 85:F4–F7.
11. Breeze ACG, Statham H, Hackett GA, Jessop FA, Lees CC: Perinatal
postmortems: what is important to parents and how do they decide?
Birth 2012, 39:57–64.
12. Ben-Sasi K, Chitty LS, Franck LS, Thayyil S, Judge-Kronis L, Taylor AM, Sebire
NJ: Acceptability of a minimally invasive perinatal/paediatric autopsy:
healthcare professionals' views and implications for practice. Prenat
Diagn 2013, 33:307–312.
13. Cannie M, Votino C, Moerman P, Vanheste R, Segers V, Van Berkel K,
Hanssens M, Kang X, Cos T, Kir M, Balepa L, Divano L, Foulon W, De Mey J,
Jani J: Acceptance, reliability and confidence of diagnosis of fetal and
neonatal virtuopsy compared with conventional autopsy: a prospective
study. Ultrasound Obstet Gynecol 2012, 39:659–665.
14. Avrahami R, Watemberg S, Daniels-Philips E, Kahana T, Hiss J: Endoscopic
autopsy. Am J Forensic Med Pathol 1995, 16:147–150.
15. Rutty GN, Brogdon G, Dedouit F, Grabherr S, Hatch GM, Jackowski C, Leth P,
Persson A, Ruder TD, Shiotani S, Takahashi N, Thali MJ, Woźniak K, Yen K,
Morgan B: Terminology used in publications for post-mortem cross-
sectional imaging. Int J Legal Med 2013, 127:465–466.
16. Brookes JA, Hall-Craggs MA, Sams VR, Lees WR: Non-invasive perinatal
necropsy by magnetic resonance imaging. The Lancet 1996, 348:1139–1141.
17. Alderliesten MEM, Peringa JJ, van der Hulst VPMV, Blaauwgeers HLGH, van
Lith JMMJ: Perinatal mortality: clinical value of postmortem magnetic
resonance imaging compared with autopsy in routine obstetric practice.
BJOG 2003, 110:378–382.
18. Woodward PJ, Sohaey R, Harris DP, Jackson GM, Klatt ED, Alexander AL,
Kennedy A: Postmortem fetal MR imaging: comparison with findings at
autopsy. Am J Roentgenol 1996, 168:41–46.
19. Griffiths PD, Variend D, Evans M, Jones A, Wilkinson ID, Paley M, Whitby E:
Postmortem MR imaging of the fetal and stillborn central nervous
system. AJNR Am J Neuroradiol 2002, 24:22–27.
20. Huisman T, Wisser J, Stallmach T: MR autopsy in fetuses. Fetal Diagn Ther
2002, 17:58–64.
21. Cohen MC, Paley MN, Griffiths PD, Whitby EH: Less invasive autopsy:
benefits and limitations of the use of magnetic resonance imaging in
the perinatal postmortem. Pediatr Dev Pathol 2008, 11:1–9.22. Thayyil S, Sebire NJ, Chitty LS, Wade A, Chong W, Olsen O, Gunny RS, Offiah
AC, Owens CM, Saunders DE, Scott RJ, Jones R, Norman W, Addison S,
Bainbridge A, Cady EB, Vita ED, Robertson NJ, Taylor AM, MARIAS
collaborative group: Post-mortem MRI versus conventional autopsy in
fetuses and children: a prospective validation study. Lancet 2013,
382:223–233.
23. Weber MA, Pryce JW, Ashworth MT, Malone M, Sebire NJ: Histological
examination in sudden unexpected death in infancy: evidence base for
histological sampling. J Clin Pathol 2012, 65:58–63.
24. Garg S, Punia RPS, Basu S, Mohan H, Bal A: Comparison of needle autopsy
with conventional autopsy in neonates. Fetal Pediatr Pathol 2009, 28:139–150.
25. Fariña J, Millana C, Fdez-Aceñero MJ, Furió V, Aragoncillo P, Martín VG,
Buencuerpo J: Ultrasonographic autopsy (echopsy): a new autopsy
technique. Virchows Arch 2002, 440:635–639.
26. Breeze ACG, Jessop FA, Whitehead AL, Set PAK, Berman L, Hackett GA, Lees
CC, for the Cambridge post mortem MRI Study Group: Feasibility of
percutaneous organ biopsy as part of a minimally invasive perinatal
autopsy. Virchows Arch 2007, 452:201–207.
27. Aghayev E, Thali MJ, Sonnenschein M, Jackowski C, Dirnhofer R, Vock P:
Post-mortem tissue sampling using computed tomography guidance.
Forensic Sci Int 2007, 166:199–203.
28. Ebert LC, Ptacek W, Naether S, Fürst M, Ross S, Buck U, Weber S, Thali M:
Virtobot–a multi-functional robotic system for 3D surface scanning and
automatic post mortem biopsy. Int J Med Robot 2010, 6:18–27.
29. Dirnhofer ST, Bubendorf L, Lehr H-A, Landau B, Zenklusen H-R:
Qualitätsrichtlinien SGPath. 2011. SGPath/SSPath. http://www.sgpath.ch/
docs/QR_SGPath_DE_2011.pdf. Accessed 9 Feb 2013.
30. Altman D, Machin D, Bryant T, Gardner S: Statistics with confidence:
confidence interval and statistical guidelines. Bristol: BMJ Books; 2000.
doi:10.1186/1471-2431-14-15
Cite this article as: Rüegger et al.: Minimally invasive, imaging guided
virtual autopsy compared to conventional autopsy in foetal, newborn
and infant cases: study protocol for the paediatric virtual autopsy trial.
BMC Pediatrics 2014 14:15.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
